The global Thalomid market is expected to grow at a moderate CAGR during the forecast period (2022-2028). Thalidomide was discovered to be extremely effective in suppressing erythema nodosum leprosum (ENL). Thalomid (thalidomide) capsules have been approved by the US Food and Drug Administration (FDA) for the acute treatment of the cutaneous manifestations of moderate […]
